Similar articles

• [Scintillation assay for evaluating chemosensitivities of human tumors--the basic principle and clinical utility].

  Tanigawa N, Takada Y, Morimoto H, Katoh Y, Maruhashi K, Nakanishi M, Tanaka T, Hashimura T, Sondak VK, Kern DH, et al. Tanigawa N, et al. Nihon Gan Chiryo Gakkai Shi. 1985 Jun 20;20(5):976-83. Nihon Gan Chiryo Gakkai Shi. 1985. PMID: 4056552 Japanese. No abstract available.
• Potentials and drawbacks of the human tumor stem cell assay.

  Shoemaker RH, Wolpert-DeFilippes MK, Venditti JM. Shoemaker RH, et al. Behring Inst Mitt. 1984 May;(74):262-72. Behring Inst Mitt. 1984. PMID: 6477356
• The human tumor stem cell assay revisited.

  Singletary SE, Umbach GE, Spitzer G, Drewinko B, Tomasovic B, Ajani J, Hug V, Blumenschein G. Singletary SE, et al. Int J Cell Cloning. 1985 Mar;3(2):116-28. doi: 10.1002/stem.5530030205. Int J Cell Cloning. 1985. PMID: 3998518
• Clonogenic and nonclonogenic in vitro chemosensitivity assays.

  Weisenthal LM, Lippman ME. Weisenthal LM, et al. Cancer Treat Rep. 1985 Jun;69(6):615-32. Cancer Treat Rep. 1985. PMID: 3893692 Review.
• [Clonogenic assays in the evaluation of antitumor chemotherapy].

  Aapro MS. Aapro MS. Schweiz Med Wochenschr. 1987 Aug 22;117(34):1266-9. Schweiz Med Wochenschr. 1987. PMID: 3313688 Review. French.